These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31636843)

  • 1. Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases.
    Choi YH; Han CY; Kim KS; Kim SG
    Toxicol Res; 2019 Oct; 35(4):319-330. PubMed ID: 31636843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for Detecting Pediatric Adverse Drug Reactions From the Electronic Medical Record.
    Joyner LM; Alicea LA; Goldman JL; Suppes SL; Tillman EM
    J Clin Pharmacol; 2021 Nov; 61(11):1479-1484. PubMed ID: 34031886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
    Tillman EM; Suppes SL; Feldman K; Goldman JL
    J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of pharmacovigilance methods in the detection of adverse drug reactions using electronic medical records.
    Liu M; McPeek Hinz ER; Matheny ME; Denny JC; Schildcrout JS; Miller RA; Xu H
    J Am Med Inform Assoc; 2013 May; 20(3):420-6. PubMed ID: 23161894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.
    Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A
    Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports.
    Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B
    Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Medication Alert Data into a Clinical Data Repository to Enable Retrospective Study of Drug Interaction Alerts in Clinical Practice.
    Liu M; Melton BL; Ator G; Waitman LR
    AMIA Jt Summits Transl Sci Proc; 2017; 2017():213-220. PubMed ID: 28815131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4/13 Blockade and sleep-related adverse drug reactions in over 37,000 Dupilumab reports from the World Health Organization Individual Case Safety reporting pharmacovigilance database (VigiBase™): a big data and machine learning analysis.
    Alroobaea R; Rubaiee S; Hanbazazah AS; Jahrami H; Garbarino S; Damiani G; Wu J; Bragazzi NL
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):4074-4081. PubMed ID: 35731078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital.
    Yu D; Sheets J; Suppes S; Goldman J
    J Clin Pharmacol; 2019 Dec; 59(12):1569-1572. PubMed ID: 31309572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.
    Shrestha S; Danekhu K; Kc B; Palaian S; Ibrahim MIM
    Ther Adv Drug Saf; 2020; 11():2042098620922480. PubMed ID: 32587678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between adverse drug reactions and unlicensed/off-label drug use in hospitalized children (EREMI): A study protocol.
    Nguyen KA; Mimouni Y; Jaberi E; Paret N; Boussaha I; Vial T; Jacqz-Aigrain E; Alberti C; Guittard L; Remontet L; Roche L; Bossard N; Kassai B
    Therapie; 2021; 76(6):675-685. PubMed ID: 33593598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions, practices and barriers to reporting of adverse drug reactions among HIV infected patients and their doctors in 3 public sector hospitals of the Ethekwini Metropolitan, Kwa-Zulu Natal: a cross sectional and retrospective analysis.
    Zondi S; Naidoo P
    BMC Health Serv Res; 2022 Aug; 22(1):1054. PubMed ID: 35982442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions.
    Neubert A; Dormann H; Prokosch HU; Bürkle T; Rascher W; Sojer R; Brune K; Criegee-Rieck M
    Br J Clin Pharmacol; 2013 Sep; 76 Suppl 1(Suppl 1):69-77. PubMed ID: 23586589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
    Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.